Reuters logo
10 个月前
BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing
2016年10月4日 / 晚上9点07分 / 10 个月前

BRIEF-Clovis oncology says entered into a manufacturing services agreement - sec filing

1 分钟阅读

Oct 4 (Reuters) - Clovis Oncology Inc

* Says Clovis Oncology and Lonza Ltd entered into a manufacturing services agreement - SEC filing

* Deal provides Lonza will be non-exclusive manufacturer of Rucaparib Api during term of deal , which expires on December 31, 2025 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below